| ALCAM | Activated Leucocyte Cell Adhesion Molecule |
| AKT | Protein kinase B |
| ANG-1 | Angiopoietin-1 |
| Bcl-XL | B-cell lymphoma-extralarge |
| BLIMP-1 | B-Lymphocyte-Induced Maturation Protein 1 |
| BM | Bone Marrow |
| BMSC | Bone Marrow Stromal Cell |
| CCL | Chemokine (C–C motif) Ligand |
| CCN | Cyclin |
| CM | Conditioned Media |
| CRD | Carbohydrate-Recognition Domains |
| DC | Dendritic Cell |
| EC | Endothelial Cell |
| ECM | Extracellular Matrix |
| ERK | Extracellular Signal-Regulated Kinases |
| FGF | Fibroblast Growth Factor |
| hGal-9 | Recombinant Protease Resistant Galectin-9 |
| H2AX | H2A histone family, member X |
| HIF-1α | Hypoxia inducible factor-1α |
| HGF | Hepatocyte Growth Factor |
| HMCL | Human Myeloma Cell Line |
| hTERT | Telomerase |
| ICAM-1 | Intercellular Adhesion Molecule 1 |
| IDO | Indoleamine-Pyrrole 2,3-Dioxygenase |
| IFN-γ | Interferon-γ |
| IGF-1 | Insuline-Like Growth Factor 1 |
| IκB | inhibitor of kappa B |
| IL | Interleukin |
| JAK | Janus Kinase |
| JNK | c-Jun N-terminal kinases |
| LAG-3 | Lymphocyte-Activation Gene 3 |
| LFA-1 | Lymphocyte Function Associate Antigen 1 |
| MCL-1 | Induced myeloid leukemia cell differentiation protein Mcl-1 |
| MCP-1 | Monocyte Chemoattractant Protein-1 |
| MDSC | Myeloid-Derived Suppressor Cells |
| MEK | Mitogen-Activated Protein Kinase Kinase 1 |
| MGUS | Monoclonal Gammopathy of Undetermined Significance |
| MM | Multiple Myeloma |
| MMD | Newly Diagnosed Myeloma |
| MMP | Metalloprotease |
| MMSET | Multiple Myeloma SET Domain |
| NF-κB | Nuclear Factor-kappa-B |
| NK | Natural Killer |
| NOXA | Phorbol-12-myristate-13-acetate-induced protein 1 |
| OB | Osteoblast |
| OC | Osteoclast |
| OPG | Osteoprotegerin |
| OPN | Osteopontin |
| OS | Overall Survival |
| PC | Plasma Cells |
| PD-1 | Programmed Cell Death-1 |
| PD-L1 | Programmed Cell Death Ligand -1 |
| PI3K | Phosphoinositide 3-Kinase |
| pre-BCR | Pre-B Cell Receptor |
| RAF1 | Raf-1 Proto-Oncogene, Serine/Threonine Kinase |
| RANKL | Receptor Activator of Nuclear Factor kappa-B Ligand |
| ROR2 | Receptor Tyrosine Kinase-Like Orphan Receptor 2 |
| RUNX2 | Runt-Related Transcription Factor 2 |
| Sema-3A | Semaphorin-3A |
| SMM | Smoldering Myeloma |
| STAT | Signal Transducers and Activators of Transcription |
| TGFβ | Transforming Growth Factor β |
| Th | T Helper |
| TIE-2 | Immunoglobulin-like and EGF-like Domains |
| TIM-3 | T-cell Immunoglobulin and Mucin-Domain Containing-3 |
| TNFα | Tumor Necrosis Factor α |
| Treg | T Regulatory |
| TT | Total Therapy |
| VCAM-1 | Vascular Cell Adhesion Molecule 1 |
| VEGFA | Vascular Endothelial Growth Factor A |
| VEGFR2 | Vascular Endothelial Growth Factor Receptor 2 |
| VLA-4 | Very Late Antigen-4 |
| WNT-5a | Wnt Family Member 5a |